Market Highlights: Wall Street falls on Fedspeak, the most crowded trades, and 5 ASX small caps to watch
ASX to open slightly lower after Wall Street fell overnight Fed’s Christopher Waller said the central bank won’t rush to cut rates And here are [more…]
PharmAust partners with US-based Berry Consultants for Phase 2/3 study
PharmAust partners with MND/ALS clinical study design and statistical analysis specialists Berry Consultants The US-based consultancy has a strong track record of clinical trial design [more…]
Taiton’s Kingsgate acquisition could be a route to near-term molybdenum production
Taiton is acquiring the Kingsgate project, which has proven high-grade molybdenum mineralisation Previous work includes extensive exploration and trial mining Molybdenum is now considered a [more…]
Bulk Buys: Rio punts on China recovery but steelmakers are still in rough shape
China’s steel output shocking rose in 2023, leading to gains for iron ore prices But they’ve fallen early doors in 2024, with Commbank predicting a [more…]
Canada Unearthed: A gold breakout is coming, says Sprott. Where are all the good precious metals stocks?
Our Canada Unearthed column wraps the news driving mining and exploration stocks listed in Canada, mostly on the TSX and TSX.V. The Aussie gold [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to 17 January, 2024 – a date on the calendar that has historically been pretty good for women in sport, but [more…]
Crypto leads in record-breaking year for Aussie ETF growth, while unlisted funds sink
BetaShares Crypto Innovators ETF (ASX:CRYP) surges 214% to be top 2023 ETF performer Aussie ETF industry records its highest annual funds under management increase in [more…]
Raised and risen: LTR Pharma floated to top of Aussie IPO pool in 2023, ahead of LU7
LTR Pharma helped prop up a flaccid Aussie IPO scene in 2023 with a winning ROI Lithium Universe wasn’t far behind, leading battery metal newcomers [more…]
Dear Eliza: Why am I even living in Melbourne?
In what is almost certainly not news, property data firm CoreLogic has released new evidence suggesting Brisbane is better than Melbourne. To be more succinct: [more…]
What’s in store for 2024: Neurotech International
Stockhead’s Ashtyn Hiron sits down with Neurotech International (ASX:NTI) executive director Dr Thomas Duthy to close the books on 2023 and gain a sneak peek into [more…]